<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Rev Inst Med Trop Sao Paulo</journal-id>
      <journal-id journal-id-type="iso-abbrev">Rev. Inst. Med. Trop. Sao Paulo</journal-id>
      <journal-id journal-id-type="publisher-id">rimtsp</journal-id>
      <journal-title-group>
        <journal-title>Revista do Instituto de Medicina Tropical de S&#xE3;o Paulo</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0036-4665</issn>
      <issn pub-type="epub">1678-9946</issn>
      <publisher>
        <publisher-name>Instituto de Medicina Tropical</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">27049711</article-id>
      <article-id pub-id-type="pmc">4727143</article-id>
      <article-id pub-id-type="doi">10.1590/S0036-46652015000600014</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>CHAGASIC MENINGOENCEPHALITIS IN AN HIV INFECTED PATIENT WITH MODERATE
IMMUNOSUPPRESSION: PROLONGED SURVIVAL AND CHALLENGES IN THE HAART ERA</article-title>
        <trans-title-group xml:lang="pt">
          <trans-title>Meningoencefalite chag&#xE1;sica em paciente infectada pelo HIV com
imunodepress&#xE3;o moderada: desafios na era HAART e sobrevida
prolongada</trans-title>
        </trans-title-group>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>BUCCHERI</surname>
            <given-names>Renata</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>KASSAB</surname>
            <given-names>Maria Jos&#xE9;</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>de FREITAS</surname>
            <given-names>Vera Lucia Teixeira</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
          <xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>da SILVA</surname>
            <given-names>Sheila Cristina Vicente</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>BEZERRA</surname>
            <given-names>Rita C.</given-names>
          </name>
          <xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>KHOURY</surname>
            <given-names>Zarifa</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>SHIKANAI-YASUDA</surname>
            <given-names>Maria Aparecida</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
          <xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>VIDAL</surname>
            <given-names>Jos&#xE9; E.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1"><label>1</label>Instituto de Infectologia Em&#xED;lio Ribas, S&#xE3;o Paulo, SP, Brasil</aff>
      <aff id="aff2"><label>2</label>Universidade de S&#xE3;o Paulo, Faculdade de Medicina, Departamento de
Mol&#xE9;stias Infecciosas e Parasit&#xE1;rias, S&#xE3;o Paulo, SP, Brasil</aff>
      <aff id="aff3"><label>3</label>Universidade S&#xE3;o Paulo, Hospital das Cl&#xED;nicas, Laborat&#xF3;rio de
Investiga&#xE7;&#xE3;o M&#xE9;dica em Imunologia (LIM 48), S&#xE3;o Paulo, SP, Brasil</aff>
      <aff id="aff4"><label>4</label>Universidade de S&#xE3;o Paulo, Hospital das Cl&#xED;nicas, Laborat&#xF3;rio de
Investiga&#xE7;&#xE3;o M&#xE9;dica em Parasitologia (LIM 46), S&#xE3;o Paulo, SP, Brasil.</aff>
      <author-notes>
        <corresp id="c01"><bold>Correspondence to:</bold> Renata Buccheri, Instituto de Infectologia Em&#xED;lio
Ribas. Av. Dr. Arnaldo 165, 8<sup>o</sup> andar. 01246-900 S&#xE3;o Paulo, SP, Brasil.
E-mail: <email>renatabuccheri@gmail.com</email></corresp>
        <fn fn-type="conflict" id="fn02">
          <p>
<bold>POTENTIAL CONFLICTS OF INTEREST</bold> The authors declare that there are no
conflicts of interest</p>
        </fn>
      </author-notes>
      <pub-date pub-type="epub-ppub">
        <season>Nov-Dec</season>
        <year>2015</year>
      </pub-date>
      <!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' -->
      <pub-date pub-type="ppub">
        <season>Nov-Dec</season>
        <year>2015</year>
      </pub-date>
      <volume>57</volume>
      <issue>6</issue>
      <fpage>531</fpage>
      <lpage>535</lpage>
      <history>
        <date date-type="received">
          <day>14</day>
          <month>3</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>22</day>
          <month>6</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0">
          <license-p>This is an open-access article distributed under the terms of the Creative
Commons Attribution License</license-p>
        </license>
      </permissions>
      <abstract>
        <p>The reactivation of Chagas disease in HIV infected patients presents high mortality
and morbidity. We present the case of a female patient with confirmed Chagasic
meningoencephalitis as AIDS-defining illness. Interestingly, her TCD4+ lymphocyte
cell count was 318 cells/mm<sup>3</sup>. After two months of induction therapy, one
year of maintenance with benznidazol, and early introduction of highly active
antiretroviral therapy (HAART), the patient had good clinical, parasitological and
radiological evolution. We used a qualitative polymerase chain reaction for the
monitoring of T. cruzi parasitemia during and after the treatment. We emphasize the
potential value of molecular techniques along with clinical and radiological
parameters in the follow-up of patients with Chagas disease and HIV infection. Early
introduction of HAART, prolonged induction and maintenance of antiparasitic therapy,
and its discontinuation are feasible, in the current management of reactivation of
Chagas disease.</p>
      </abstract>
      <trans-abstract xml:lang="pt">
        <p>A reativa&#xE7;&#xE3;o da doen&#xE7;a de Chagas em pacientes com a infec&#xE7;&#xE3;o pelo HIV apresenta uma
alta morbidade e mortalidade. Neste relato, apresentamos caso confirmado de
meningoencefalite chag&#xE1;sica, como doen&#xE7;a definidora de aids, em paciente com 318
linf&#xF3;citos T-CD4+/mm3. Ap&#xF3;s 2 meses de tratamento seguido de um ano de profilaxia
secund&#xE1;ria com benzonidazol e in&#xED;cio precoce de terapia antirretroviral (HAART), a
paciente apresentou boa evolu&#xE7;&#xE3;o cl&#xED;nica, parasitol&#xF3;gica e radiol&#xF3;gica. Utilizamos a
rea&#xE7;&#xE3;o em cadeia da polimerase qualitativa do T. cruzi, para monitoriza&#xE7;&#xE3;o da
parasitemia por T. cruzi durante e ap&#xF3;s o tratamento. Ressaltamos o valor potencial
das t&#xE9;cnicas moleculares associadas aos par&#xE2;metros cl&#xED;nicos e radiol&#xF3;gicos nos
pacientes com doen&#xE7;a de Chagas e infec&#xE7;&#xE3;o pelo HIV. A introdu&#xE7;&#xE3;o precoce da terapia
antirretroviral, a terapia antiparasit&#xE1;ria prolongada, manuten&#xE7;&#xE3;o e descontinua&#xE7;&#xE3;o da
mesma, s&#xE3;o desafios atuais, embora poss&#xED;veis, no manejo da reativa&#xE7;&#xE3;o da doen&#xE7;a de
Chagas na era das terapias antirretrovirais de alta efic&#xE1;cia.</p>
      </trans-abstract>
      <kwd-group>
        <kwd>Chagas disease</kwd>
        <kwd>Meningoencephalitis</kwd>
        <kwd>Central nervous system</kwd>
        <kwd>Acquired immunodeficiency syndrome</kwd>
      </kwd-group>
      <funding-group>
        <award-group>
          <funding-source>Funda&#xE7;&#xE3;o de Amparo &#xE0; Pesquisa do Estado de S&#xE3;o Paulo</funding-source>
          <award-id>12/50273-0</award-id>
        </award-group>
        <funding-statement>This study was partially supported by the <italic>Centro de Estudos
Em&#xED;lio Ribas</italic>, <italic>Instituto de Infectologia Em&#xED;lio Ribas</italic> and
the <italic>Funda&#xE7;&#xE3;o de Amparo &#xE0; Pesquisa do Estado de S&#xE3;o Paulo</italic> - FAPESP,
Proc. FAPESP 12/50273-0.</funding-statement>
      </funding-group>
      <counts>
        <fig-count count="3"/>
        <table-count count="0"/>
        <equation-count count="0"/>
        <ref-count count="33"/>
        <page-count count="5"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>INTRODUCTION</title>
      <p>The co-infection <italic>Trypanosoma cruzi</italic>/HIV was first described in the
1990s, showing the opportunist character of <italic>T. cruzi</italic> in the presence of
immunosuppression<xref rid="B12" ref-type="bibr">12</xref>
<sup>,</sup>
<xref rid="B16" ref-type="bibr">16</xref>
<sup>,</sup>
<xref rid="B18" ref-type="bibr">18</xref>. The Ministry of Health of Brazil included the
reactivation of Chagas disease in the list of AIDS defining illness in 2004<xref rid="B06" ref-type="bibr">6</xref>. However, the true prevalence of co-infection is
not well known, and its actual frequency of reactivation is estimated at 20%<xref rid="B28" ref-type="bibr">28</xref>. The magnitude of AIDS and Chagas disease in
Brazil, as chronic conditions, increases the possibility of cases of reactivation
therefore increasing the incidence of this medical condition<xref rid="B03" ref-type="bibr">3</xref>. </p>
      <p>In Brazil there are about 2 to 3 million people infected with <italic>T. cruzi</italic>,
where Chagas disease, as the underlying disease was the fourth leading cause of death
(10.8%) among all infectious and parasitic diseases<xref rid="B22" ref-type="bibr">22</xref>. Furthermore, considering cases of HIV/AIDS, it was demonstrated that the
frequency of co-infections was up to 1.3%<xref rid="B19" ref-type="bibr">19</xref>. A
recent transversal study has reported a high rate of the disease reactivation in a
co-infected population (41.2%), the central nervous system (CNS) being the main site of
reactivation, representing 74% of cases. However, signs and symptoms are nonspecific,
ranging from headache, intracranial hypertension, seizures, and coma leading to
diagnostic confusion, mainly with toxoplasmosis and tumors of the central nervous
system<sup>3</sup>. </p>
      <p>Some of the predictors of the incidence of Chagas disease reactivation are the detection
of parasitemia, low TCD4+ lymphocyte values (&lt; 200 cells/mm<sup>3</sup>) and high
viral load of HIV, although these are not essential to its occurrence<xref rid="B03" ref-type="bibr">3</xref>
<sup>,</sup>
<xref rid="B09" ref-type="bibr">9</xref>
<sup>,</sup>
<xref rid="B12" ref-type="bibr">12</xref>
<sup>,</sup>
<xref rid="B23" ref-type="bibr">23</xref>
<sup>,</sup>
<xref rid="B27" ref-type="bibr">27</xref>. Recently, it was suggested that the
monitoring of reactivation must be performed by parasitemia and/or molecular analyses as
well as the degree of immunosuppression<xref rid="B15" ref-type="bibr">15</xref>
<sup>,</sup>
<xref rid="B17" ref-type="bibr">17</xref>
<sup>,</sup>
<xref rid="B27" ref-type="bibr">27</xref>. The reactivation of Chagas disease in
patients with HIV co-infection is associated with high mortality related to several
factors, including the occurrence of reactivation in the CNS, which is frequently fatal
without specific treatment<xref rid="B02" ref-type="bibr">2</xref>
<sup>,</sup>
<xref rid="B03" ref-type="bibr">3</xref>
<sup>,</sup>
<xref rid="B29" ref-type="bibr">29</xref>, and the severe immunosuppression of AIDS
patients.</p>
      <p>We report a case of meningoencephalitis caused by reactivation of Chagas disease in a
patient with recent diagnosis of AIDS, who presented a favorable clinical,
parasitological and radiological evolution after treatment with benznidazole and
antiretroviral therapy. </p>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p>A forty-two-year-old female patient, who spent her childhood and adolescence in a rural
area in Bahia State, has been living in an urban area of S&#xE3;o Paulo State for the last 23
years. One month before admission, the patient was diagnosed with HIV infection. She was
admitted to our hospital with a history of progressive loss of strength in left upper
and lower limbs, and seizures, for 15 days. On the day of admission, she presented a new
seizure. Upon physical examination, the patient was febrile, hemodynamically stable,
disoriented in time and space, and presenting left hemiparesis. Hemoglobin in blood
revealed 15 mg/dL and leukocytes = 5000 cells/mm<sup>3</sup> (61% neutrophils, 29%
lymphocytes, 8% monocytes). The biochemical tests did not detect any alterations.
Cranial tomography (CT) scan showed findings compatible with encephalitis (<xref ref-type="fig" rid="f01">Fig. 1</xref>A). Examination of cerebrospinal fluid (CSF)
showed cells = 16 (94% lymphocytes, 6% monocytes, 0% neutrophils), proteins = 71 mg/dL,
and glucose = 50 mg/dL. Blood and cerebrospinal fluid (CSF) cultures were performed to
isolate bacteria, fungi and mycobacteria, and they showed no growth. Empirical treatment
was initiated to cerebral toxoplasmosis with sulfadiazine, pyrimethamine and folinic
acid combined with dexamethasone. The patient had TCD4+ lymphocyte count = 318
cells/mm<sup>3</sup>and HIV-1 RNA = 26.168 copies/mL. Serology for <italic>Toxoplasma
gondii</italic> showed reactive IgG antibodies and non-reactive IgM antibodies. Ten
days after the start of empirical treatment for cerebral toxoplasmosis, the patient
presented nausea and vomiting associated with decreased level of consciousness. A new CT
scan revealed increased mass effect in the right fronto-temporo-parietal area (<xref ref-type="fig" rid="f01">Fig. 1</xref>B). Another lumbar puncture was performed
showing cells = 5 (91% lymphocytes, 6% monocytes, 1% neutrophils), proteins = 42mg/dL,
and glucose = 63mg/dL. The direct examination of CSF showed trypomastigotes compatible
with <italic>T. cruzi</italic> and the polymerase chain reaction (PCR) identified DNA of
this parasite<xref rid="B19" ref-type="bibr">19</xref>
<sup>,</sup>
<xref rid="B30" ref-type="bibr">30</xref>
<sup>,</sup>
<xref rid="B33" ref-type="bibr">33</xref>. PCR of the CSF for <italic>T.
gondii</italic>; Epstein Barr virus and JC virus were negative. Serological tests for
<italic>T. cruzi</italic> (ELISA and passive hemagglutination) were reactive with the
latter presenting titration of 1:128. Heart and digestive involvement were excluded by
echocardiogram, X-ray of the chest with barium contrast medium and barium enema,
respectively. Direct analysis of <italic>T. cruzi</italic> in peripheral blood was
negative, qualitative PCR was positive in blood, and blood culture was positive for
<italic>T. cruzi.</italic> Benznidazole was prescribed, 5 mg/kg twice a day, and
treatment for cerebral toxoplasmosis was interrupted. Two weeks later, the patient
showed partial improvement of the focal deficit, still with limitations in walking and
moderate psychomotor slowing. Zidovudine, lamivudine and lopinavir/ritonavir were
introduced. Qualitative PCR monitoring of <italic>T. cruzi</italic> DNA in blood and
CSF, on days seven, 14, 30, and 60 of treatment showed negative results. After two
months of treatment with benznidazole, the patient showed clear neurological
improvement, with residual hemiparesis, walking unaided, and with slight psychomotor
slowing. At this time, magnetic resonance imaging (MRI) of the brain showed signs of
meningoencephalitis in regression (<xref ref-type="fig" rid="f02">Fig. 2</xref>). The
patient was discharged with secondary prophylaxis, receiving benznidazole three times a
week. Four months after diagnosis, the patient had progressive neurological improvement,
with mild left hemiparesis and mild psychomotor slowing. A new MRI also showed
improvement in the previously observed signs of disease (<xref ref-type="fig" rid="f03">Fig. 3</xref>). Tests showed TCD4+ lymphocyte = 416 (18%) and HIV viral load &lt; 50
copies/mL. After a year of follow-up, the patient remained with stable neurological
sequelae (mild left hemiparesis and psychomotor slowing) and secondary prophylaxis with
benznidazol was interrupted. Qualitative PCR in blood for <italic>T. cruzi</italic> was
negative. The TCD4+ lymphocyte count was 349 (13%) and HIV viral load &lt; 50 copies/mL.
Six months after discontinuation of secondary prophylaxis, the patient remained
clinically stable. </p>
      <p>
<fig id="f01" orientation="portrait" position="float"><label>Fig. 1</label><caption><title>
<bold>-</bold> Contrasted brain computed tomography scan. A) CT at admission
showing bilateral areas of gyral enhancement with regional edema, particularly
in the right temporo-parietal region; B) CT after 10 days of admission showing
persistent gyral enhancement and worsening of adjacent edema in the right
temporo-parietal region.</title></caption><graphic xlink:href="0036-4665-rimtsp-57-06-00531-gf01"/></fig>
</p>
      <p>
<fig id="f02" orientation="portrait" position="float"><label>Fig. 2</label><caption><title>
<bold>-</bold> Magnetic resonance imaging two months after the diagnosis of
chagasic meningoencephalitis. A) MRI T1 with gadolinium. Gyral enhancement in
the right temporo-parietal region; B and C) MRI T2 and FLAIR, respectively.
Focus of hyperintensity adjacent to the images described in T1.</title></caption><graphic xlink:href="0036-4665-rimtsp-57-06-00531-gf02"/></fig>
</p>
      <p>
<fig id="f03" orientation="portrait" position="float"><label>Fig. 3</label><caption><title>
<bold>-</bold> Magnetic resonance imaging four months after the diagnosis of
chagasic meningoencephalitis. A, B and C) MRI T1 with gadolinium, T2 and FLAIR,
respectively. Findings consistent with partial regression of the findings
described two months before. The dilation of the posterior right lateral
ventricle due to adjacent encephalomalacia is noted.</title></caption><graphic xlink:href="0036-4665-rimtsp-57-06-00531-gf03"/></fig>
</p>
      <p>The parasite was identified directly in the blood by a three-marker sequential typing
strategy<xref rid="B19" ref-type="bibr">19</xref>
<sup>,</sup>
<xref rid="B30" ref-type="bibr">30</xref>
<sup>,</sup>
<xref rid="B33" ref-type="bibr">33</xref> consisting of PCR amplification of the D7
divergent domain of the 24Sa rDNA gene, PCR-RFLP of the heat shock protein 60 (HSP60)
and glucose-6-phosphate isomerase as TC II, usually responsive to benznidazole. </p>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>Although Brazil leads the number of cases of reactivation of Chagas disease in
HIV-infected patients<xref rid="B26" ref-type="bibr">26</xref>, the real extension of
the problem is unknown, due to underdiagnosis and underreporting of cases<xref rid="B03" ref-type="bibr">3</xref>. Vector-borne and transfusion transmission of
Chagas disease have been successfully controlled in Brazil. Such measures are based on
insecticide chemical treatment of dwellings in endemic areas and rigorous blood bank
control<xref rid="B14" ref-type="bibr">14</xref>. Nevertheless, Chagas disease
remains a public health concern in many geographic areas. The main scenario pertains to
northeastern Brazil, where the species <italic>Triatoma brasiliensis</italic> and
<italic>T. pseudomaculata</italic> present potential epidemiological importance for
transmission of disease in this area<xref rid="B07" ref-type="bibr">7</xref>
<sup>,</sup>
<xref rid="B08" ref-type="bibr">8</xref>. Both species have been captured in
peridomestic environments and natural semiarid ecosystems, where high rates of
<italic>T. cruzi</italic> infection have been reported<xref rid="B30" ref-type="bibr">30</xref>. Of note, our patient came from a rural area of Bahia and considering the
eco-epidemiological situation, she probably acquired the infection through vectorial
route.</p>
      <p>Reactivation of Chagas disease in the CNS presents two frequent clinical forms: diffuse,
acute or subacute meningoencephalitis (multiple foci of necrotic-encephalitis), and/or
intracranial mass lesion, known as "chagoma" (isolated or multiple necrotic-hemorrhagic
nodular lesions)<sup>26.</sup> At the <italic>Instituto de Infectologia Em&#xED;lio
Ribas</italic>, Sao Paulo, Brazil, in patients with meningeal syndrome, the most
common causes are cryptococcosis, tuberculosis and syphilis. On the other hand, the
syndromes in which there is a predominance of one or more brain mass lesions, are
cerebral toxoplasmosis, tuberculomas, and CNS primary lymphoma<xref rid="B21" ref-type="bibr">21</xref>. </p>
      <p>Considering the lack of specificity of clinical and radiological information, it is
important to consider <italic>T. cruzi</italic> as a differential diagnosis in
meningoencephalitis with or without focal brain lesion in patients with HIV/AIDS from
countries where this disease is endemic and who lived in rural areas, are intravenous
drug users, and also in those having received blood transfusion<xref rid="B11" ref-type="bibr">11</xref>
<sup>,</sup>
<xref rid="B15" ref-type="bibr">15</xref>
<sup>,</sup>
<xref rid="B25" ref-type="bibr">25</xref>. In chagasic meningoencephalitis, the
diagnosis of reactivation is based on parasite visualization by direct microscopy in
cerebrospinal fluid samples<xref rid="B04" ref-type="bibr">4</xref>
<sup>,</sup>
<xref rid="B17" ref-type="bibr">17</xref>. The diagnosis is often incidental, since more
frequent etiologies are usually expected. Direct observation of the parasite in
peripheral blood can help the diagnosis, however, it may be negative, as in the present
case. The diagnosis of "chagoma" without meningoencephalitis is more difficult due to
the need of pathological confirmation. The absence of anti-<italic>Toxoplasma</italic>
antibodies in patients with HIV infection who have one or more expansive lesions should
raise clinical suspicion of alternative diseases, including Chagas disease. The presence
of anti-<italic>T. cruzi</italic> antibodies is important in the initial approach. On
the other hand, patients without clinical and radiological improvement after 10-14 days
of empirical treatment for cerebral toxoplasmosis should also be carefully reevaluated.
Most patients with neurological reactivation of Chagas disease presents TCD4+ lymphocyte
count &lt; 200 cells/mm<sup>3</sup>. In a systematic review from 1980 to 2010, held in
Brazil, 120 cases of reactivation of Chagas disease were evaluated and an average of
TCD4+ lymphocytes of 98 cells/mm<sup>3</sup> was reported<xref rid="B03" ref-type="bibr">3</xref>. Most patients with neurological reactivation died shortly after diagnosis
or during treatment<xref rid="B29" ref-type="bibr">29</xref>. The mortality rate is
approximately 85%, even in patients receiving treatment, mainly due to delayed diagnosis
and severe immunosuppression<xref rid="B10" ref-type="bibr">10</xref>. In contrast, in
the present case, the patient presented low TCD4+ lymphocyte count but higher than 200
cells/mm<sup>3</sup>, a condition that may have modulated appropriately the
therapeutic response even after neurological deterioration during the empirical
treatment for cerebral toxoplasmosis with antiparasitic drug and corticosteroids. As
previously described, higher rates of parasitemia appear to be related to higher doses
of corticosteroids<xref rid="B28" ref-type="bibr">28</xref>. Nevertheless, in the
present case, clinical manifestations of Chagas disease were present before the
introduction of corticosteroids, suggesting that the major factor for reactivation was
the immunosuppression related to AIDS. </p>
      <p>There is scarce information on the clinical use of molecular techniques in HIV-infected
patients with neurological manifestations in the context of reactivation of Chagas
disease<xref rid="B13" ref-type="bibr">13</xref>
<sup>,</sup>
<xref rid="B27" ref-type="bibr">27</xref>. Qualitative positive PCR in peripheral blood
can be found in patients with chronic Chagas disease, making the diagnosis of
reactivation even more difficult, being the gold standard represented by the
identification of parasites by direct microscopy in biological fluids. On the other
hand, qualitative or quantitative PCR are useful tools for therapeutic monitoring but
little information is available in the CSF<xref rid="B13" ref-type="bibr">13</xref>
<sup>,</sup>
<xref rid="B24" ref-type="bibr">24</xref>. As noted in this case, we consider the
sequential results of qualitative PCR in both peripheral blood and cerebrospinal fluid
for therapeutic monitoring, always in combination with clinical and radiographic
findings. Opportune treatment with benznidazole may help to improve survival rates.
Nevertheless, long-term prognosis of HIV-infected patients who have neurological
reactivation of Chagas disease depends on the immunological and virological control due
to the use of antiretroviral therapy<xref rid="B15" ref-type="bibr">15</xref>
<sup>,</sup>
<xref rid="B21" ref-type="bibr">21</xref>.</p>
      <p>Before the advent of HAART, the prognosis of Chagas disease reactivation in HIV-infected
patients was poor<xref rid="B15" ref-type="bibr">15</xref>. Based on cases reported in
the literature after the HAART era, survival reaches three to five years. In all of
these cases and as shown in our patient, therapy for Chagas disease was maintained for a
long period and secondary prophylaxis was continued until virological suppression and
substantial immune recovery were achieved<xref rid="B11" ref-type="bibr">11</xref>
<sup>,</sup>
<xref rid="B15" ref-type="bibr">15</xref>. Moreover, the discontinuation of secondary
prophylaxis is an issue still unknown but usually performed as an extrapolation of the
management of other opportunistic infections<xref rid="B15" ref-type="bibr">15</xref>
<sub>.</sub>Considering that there are no well documented cases of inflammatory syndrome
of immune reconstitution associated with Chagas disease, the current recommendation is
to start or adjust antiretroviral therapy as soon as the patient is clinically
stable<xref rid="B24" ref-type="bibr">24</xref>. In the present case, HAART was
initiated two weeks after the initiation of the antiparasitic treatment. The duration of
Chagas disease treatment has not been formally evaluated in HIV-infected patients, but
benznidazole is recommended, 5-8 mg/kg/day, orally, in two doses for 60 days. The need,
composition, and duration of the maintenance treatment are also controversial,
particularly in the HAART era. However, considering the available information, we
prescribed benznidazole 2.5-5 mg/kg/day, three times a week, until stable immune
reconstitution was achieved<xref rid="B05" ref-type="bibr">5</xref>
<sup>,</sup>
<xref rid="B11" ref-type="bibr">11</xref>
<sup>,</sup>
<xref rid="B32" ref-type="bibr">32</xref>. In the presence of reactivation with 318
TCD4+ lymphocytes count, we suggest that the effective control of viremia by HAART
associated with a period of maintenance treatment of six-12 months, increased TCD4+
lymphocyte count, and negative PCR in blood may represent sufficient parameters for
discontinuation of the antiparasitic therapy. </p>
      <p>In conclusion, we report the case of a patient with chagasic meningoencephalitis as
AIDS-defining illness, despite having TCD4+ lymphocyte counts &gt; 200
cells/mm<sup>3</sup>. We emphasize the potential value of therapeutic monitoring
using molecular techniques, associated with clinical and radiological parameters.
Nowadays, early introduction of HAART, prolonged induction and maintenance of
antiparasitic therapy, and its discontinuation represent real targets in the current
management of reactivation of Chagas disease in HIV-infected patients.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="financial-disclosure" id="fn01">
        <p>
<bold>FINANCIAL SUPPORT</bold> This study was partially supported by the
<italic>Centro de Estudos Em&#xED;lio Ribas</italic>, <italic>Instituto de Infectologia
Em&#xED;lio Ribas</italic> and the <italic>Funda&#xE7;&#xE3;o de Amparo &#xE0; Pesquisa do Estado de
S&#xE3;o Paulo</italic> - FAPESP, Proc. FAPESP 12/50273-0.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="B01">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Almeida</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Ramos</surname>
              <given-names>AN</given-names>
              <suffix>J&#xFA;nior</suffix>
            </name>
            <name>
              <surname>Correia</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Shikanai-Yasuda</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
          <article-title>Rede Brasileira de Aten&#xE7;&#xE3;o e Estudos na co-infec&#xE7;&#xE3;o Trypanosoma
cruzi/HIV e em outras condi&#xE7;&#xF5;es de imunossupress&#xE3;o</article-title>
          <source>Rev Soc Bras Med Trop</source>
          <year>2009</year>
          <volume>42</volume>
          <fpage>605</fpage>
          <lpage>608</lpage>
          <pub-id pub-id-type="pmid">19967250</pub-id>
        </element-citation>
      </ref>
      <ref id="B02">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Almeida</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Lima</surname>
              <given-names>JN</given-names>
            </name>
            <name>
              <surname>Lages-Silva</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Guariento</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Aoki</surname>
              <given-names>FH</given-names>
            </name>
            <name>
              <surname>Torres-Morales</surname>
              <given-names>AE</given-names>
            </name>
          </person-group>
          <article-title>Chagas' disease and HIV co-infection in patients without effective
antiretroviral therapy: prevalence, clinical presentation and natural
history</article-title>
          <source>Trans R Soc Trop Med Hyg</source>
          <year>2010</year>
          <volume>104</volume>
          <fpage>447</fpage>
          <lpage>452</lpage>
          <pub-id pub-id-type="pmid">20303560</pub-id>
        </element-citation>
      </ref>
      <ref id="B03">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Almeida</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Ramos</surname>
              <given-names>AN</given-names>
              <suffix>J&#xFA;nior</suffix>
            </name>
            <name>
              <surname>Correia</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Shikanai-Yasuda</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
          <article-title>Co-infection Trypanosoma cruzi/HIV: systematic review
(1980-2010)</article-title>
          <source>Rev Soc Bras Med Trop</source>
          <year>2011</year>
          <volume>44</volume>
          <fpage>762</fpage>
          <lpage>770</lpage>
          <pub-id pub-id-type="pmid">22231251</pub-id>
        </element-citation>
      </ref>
      <ref id="B04">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Amato</surname>
              <given-names>V</given-names>
              <suffix>Neto</suffix>
            </name>
            <name>
              <surname>Lopes</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>De Marchi</surname>
              <given-names>CR</given-names>
            </name>
            <name>
              <surname>Silva</surname>
              <given-names>MF</given-names>
            </name>
          </person-group>
          <article-title>Tentativa de evidenciar o Trypanosoma cruzi no sangue perif&#xE9;rico de
pacientes com doen&#xE7;a de Chagas, em fase cr&#xF4;nica por meio do quantitative buffy
coat (QBC)</article-title>
          <source>Rev Soc Bras Med Trop</source>
          <year>1998</year>
          <volume>31</volume>
          <fpage>231</fpage>
          <lpage>233</lpage>
          <pub-id pub-id-type="pmid">9608243</pub-id>
        </element-citation>
      </ref>
      <ref id="B05">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <collab>Brasil. Minist&#xE9;rio da Sa&#xFA;de</collab>
          </person-group>
          <article-title>Recomenda&#xE7;&#xF5;es para diagn&#xF3;stico, tratamento e acompanhamento da
co-infec&#xE7;&#xE3;o Trypanosoma cruzi: v&#xED;rus da imunodefici&#xEA;ncia humana</article-title>
          <source>Rev Soc Bras Med Trop</source>
          <year>2006</year>
          <volume>39</volume>
          <fpage>392</fpage>
          <lpage>341</lpage>
          <pub-id pub-id-type="pmid">17119760</pub-id>
        </element-citation>
      </ref>
      <ref id="B06">
        <label>6</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <collab>Brasil. Minist&#xE9;rio da Sa&#xFA;de. Secretaria de Vigil&#xE2;ncia em Sa&#xFA;de</collab>
          </person-group>
          <source>Programa Nacional de DST e AIDS</source>
          <edition> Crit&#xE9;rios de defini&#xE7;&#xE3;o de casos de AIDS em adultos e crian&#xE7;as</edition>
          <publisher-loc>Bras&#xED;lia</publisher-loc>
          <publisher-name>Minist&#xE9;rio da Sa&#xFA;de</publisher-name>
          <year>2004</year>
        </element-citation>
      </ref>
      <ref id="B07">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Carbajal de la Fuente</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Minoli</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Lopes</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Noireau</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Lazzari</surname>
              <given-names>CR</given-names>
            </name>
            <name>
              <surname>Lorenzo</surname>
              <given-names>MG</given-names>
            </name>
          </person-group>
          <article-title>Flight dispersal of the Chagas disease vectors Triatoma brasiliensis
and Triatoma pseudomaculata in northeastern Brazil</article-title>
          <source>Acta Trop</source>
          <year>2007</year>
          <volume>101</volume>
          <fpage>115</fpage>
          <lpage>119</lpage>
          <pub-id pub-id-type="pmid">17292320</pub-id>
        </element-citation>
      </ref>
      <ref id="B08">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Carbajal de la Fuente</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Dias-Lima</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Lopes</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Emperaire</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Walter</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ferreira</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Behavioral plasticity of Triatominae related to habitat selection in
northeast Brazil</article-title>
          <source>J Med Entomol</source>
          <year>2008</year>
          <volume>45</volume>
          <fpage>14</fpage>
          <lpage>19</lpage>
          <pub-id pub-id-type="pmid">18283937</pub-id>
        </element-citation>
      </ref>
      <ref id="B09">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Castro</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>de Mecca</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Bartel</surname>
              <given-names>LC</given-names>
            </name>
          </person-group>
          <article-title>Toxic effects of drugs used to treat Chagas' disease (American
trypanosomiasis)</article-title>
          <source>Hum Exp Toxicol</source>
          <year>2006</year>
          <volume>25</volume>
          <fpage>471</fpage>
          <lpage>479</lpage>
          <pub-id pub-id-type="pmid">16937919</pub-id>
        </element-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>C&#xF3;rdova</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Maiolo</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Corti</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ordu&#xF1;a</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Neurological manifestations of Chagas' disease</article-title>
          <source>Neurol Res</source>
          <year>2010</year>
          <volume>32</volume>
          <fpage>238</fpage>
          <lpage>244</lpage>
          <pub-id pub-id-type="pmid">20406601</pub-id>
        </element-citation>
      </ref>
      <ref id="B11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Corti</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Yampolsky</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Prolonged survival and immune reconstitution after chagasic
meningoencephalitis in a patient with acquired immunodeficiency
syndrome</article-title>
          <source>Rev Soc Bras Med Trop</source>
          <year>2006</year>
          <volume>39</volume>
          <fpage>85</fpage>
          <lpage>88</lpage>
          <pub-id pub-id-type="pmid">16501775</pub-id>
        </element-citation>
      </ref>
      <ref id="B12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Del Castillo</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Mendoza</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Ovieda</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Perez Bianco</surname>
              <given-names>RP</given-names>
            </name>
            <name>
              <surname>Anselmo</surname>
              <given-names>AE</given-names>
            </name>
            <name>
              <surname>Silva</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>AIDS and Chagas' disease with central nervous system tumor-like
lesion</article-title>
          <source>Am J Med</source>
          <year>1990</year>
          <volume>88</volume>
          <fpage>693</fpage>
          <lpage>694</lpage>
          <pub-id pub-id-type="pmid">2111972</pub-id>
        </element-citation>
      </ref>
      <ref id="B13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>de Freitas</surname>
              <given-names>VL</given-names>
            </name>
            <name>
              <surname>da Silva</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Sartori</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Bezerra</surname>
              <given-names>RC</given-names>
            </name>
            <name>
              <surname>Westphalen</surname>
              <given-names>EV</given-names>
            </name>
            <name>
              <surname>Molina</surname>
              <given-names>TD</given-names>
            </name>
          </person-group>
          <article-title>Real-time PCR in HIV/Trypanosoma cruzi coinfection with and without
Chagas disease reactivation: association with HIV viral load and CD4
level</article-title>
          <source>PLOS Negl Trop Dis</source>
          <year>2011</year>
          <volume>5</volume>
          <elocation-id/>
        </element-citation>
      </ref>
      <ref id="B14">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dias</surname>
              <given-names>JC</given-names>
            </name>
          </person-group>
          <article-title>Elimination of Chagas disease transmission:
perspectives</article-title>
          <source>Mem Inst Oswaldo Cruz</source>
          <year>2009</year>
          <volume>104</volume>
          <issue>Suppl 1</issue>
          <fpage>41</fpage>
          <lpage>45</lpage>
          <pub-id pub-id-type="pmid">19753456</pub-id>
        </element-citation>
      </ref>
      <ref id="B15">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Diaz Granados</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Saavedra-Trujillo</surname>
              <given-names>CH</given-names>
            </name>
            <name>
              <surname>Mantilla</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Valderrama</surname>
              <given-names>SL</given-names>
            </name>
            <name>
              <surname>Alquichire</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Franco-Paredes</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Chagasic encephalitis in HIV patients: common presentation of an
evolving epidemiological and clinical association</article-title>
          <source>Lancet Infect Dis</source>
          <year>2009</year>
          <volume>9</volume>
          <fpage>324</fpage>
          <lpage>330</lpage>
          <pub-id pub-id-type="pmid">19393962</pub-id>
        </element-citation>
      </ref>
      <ref id="B16">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ferreira</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Nishioka</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Silvestre</surname>
              <given-names>MT</given-names>
            </name>
            <name>
              <surname>Borges</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Nunes-Ara&#xFA;jo</surname>
              <given-names>FR</given-names>
            </name>
            <name>
              <surname>Rocha</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Reactivation of Chagas' disease in patients with AIDS: report of three
new cases and review of the literature</article-title>
          <source>Clin Infect Dis</source>
          <year>1997</year>
          <volume>25</volume>
          <fpage>1397</fpage>
          <lpage>1400</lpage>
          <pub-id pub-id-type="pmid">9431385</pub-id>
        </element-citation>
      </ref>
      <ref id="B17">
        <label>17</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Freilij</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Muller</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Gonzalez</surname>
              <given-names>Cappa</given-names>
            </name>
          </person-group>
          <article-title>SM Direct micromethod for diagnosis of acute and congenital Chagas
disease</article-title>
          <source>J Clin Microbiol</source>
          <year>1983</year>
          <volume>18</volume>
          <fpage>327</fpage>
          <lpage>330</lpage>
          <pub-id pub-id-type="pmid">6413530</pub-id>
        </element-citation>
      </ref>
      <ref id="B18">
        <label>18</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Harms</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Feldmeir</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>The impact of HIV infection on tropical disease</article-title>
          <source>Infect Dis Clin North Am</source>
          <year>2005</year>
          <volume>19</volume>
          <fpage>121</fpage>
          <lpage>135</lpage>
          <pub-id pub-id-type="pmid">15701550</pub-id>
        </element-citation>
      </ref>
      <ref id="B19">
        <label>19</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jesus-Pedro</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Doen&#xE7;a de Chagas e s&#xED;ndrome da imunodefici&#xEA;ncia adquirida: quantos
estariam co-infectados no Brasil?</article-title>
          <source>J Bras AIDS</source>
          <year>2001</year>
          <volume>2</volume>
          <fpage>5</fpage>
          <lpage>6</lpage>
        </element-citation>
      </ref>
      <ref id="B20">
        <label>20</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lewis</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>Ma</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Yeo</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Carrasco</surname>
              <given-names>HJ</given-names>
            </name>
            <name>
              <surname>Llewellyn</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Miles</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
          <article-title>Genotyping of Trypanosoma cruzi: systematic selection of assays
allowing rapid and accurate discrimination of all known lineages</article-title>
          <source>Am J Trop Med Hyg</source>
          <year>2009</year>
          <volume>81</volume>
          <fpage>1041</fpage>
          <lpage>1049</lpage>
          <pub-id pub-id-type="pmid">19996435</pub-id>
        </element-citation>
      </ref>
      <ref id="B21">
        <label>21</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Madalosso</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Pellini</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Vasconcelos</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Ribeiro</surname>
              <given-names>AF</given-names>
            </name>
            <name>
              <surname>Weissmann</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Oliveira</surname>
              <given-names>GO</given-names>
              <suffix>Filho</suffix>
            </name>
          </person-group>
          <article-title>Chagasic meningoencephalites: case report of a recently included
AIDS-defining illness in Brazil</article-title>
          <source>Rev Inst Med Trop Sao Paulo</source>
          <year>2004</year>
          <volume>46</volume>
          <fpage>199</fpage>
          <lpage>202</lpage>
          <pub-id pub-id-type="pmid">15361971</pub-id>
        </element-citation>
      </ref>
      <ref id="B22">
        <label>22</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Martins-Melo</surname>
              <given-names>FR</given-names>
            </name>
            <name>
              <surname>Alencar</surname>
              <given-names>CH</given-names>
            </name>
            <name>
              <surname>Ramos AN</surname>
              <given-names>Jr</given-names>
            </name>
            <name>
              <surname>Heukelbach</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Epidemiology of mortality related to Chagas' disease in Brazil,
1999-2007</article-title>
          <source>PLOS Negl Trop Dis</source>
          <year>2012</year>
          <volume>6</volume>
          <elocation-id/>
        </element-citation>
      </ref>
      <ref id="B23">
        <label>23</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nishioka</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Ferreira</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Rocha</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Burgarelli</surname>
              <given-names>MK</given-names>
            </name>
            <name>
              <surname>Silva</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Duarte</surname>
              <given-names>MI</given-names>
            </name>
          </person-group>
          <article-title>Reactivation of Chagas' disease successfully treated with benznidazole
in a patient with acquired immunodeficiency syndrome</article-title>
          <source>Mem Inst Oswaldo Cruz</source>
          <year>1993</year>
          <volume>88</volume>
          <fpage>493</fpage>
          <lpage>496</lpage>
          <pub-id pub-id-type="pmid">8107611</pub-id>
        </element-citation>
      </ref>
      <ref id="B24">
        <label>24</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <collab>Panel on Opportunistic Infections in HIV-Infected Adults and
Adolescents</collab>
          </person-group>
          <source>Guidelines for the prevention and treatment of opportunistic infections in
HIV-infected adults and adolescents: recommendations from the Centers for Disease
Control and Prevention, the National Institutes of Health, and the HIV Medicine
Association of the Infectious Diseases Society of America</source>
          <year>2014</year>
          <ext-link ext-link-type="uri" xlink:href="http://aidsinfo.nih.gov/contentfiles/lvguidelines/adult_oi.pdf">http://aidsinfo.nih.gov/contentfiles/lvguidelines/adult_oi.pdf</ext-link>
        </element-citation>
      </ref>
      <ref id="B25">
        <label>25</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pinazo</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Espinosa</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Cortes-Lletget</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Posada</surname>
              <given-names>EJ</given-names>
            </name>
            <name>
              <surname>Aldasoro</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Oliveira</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
          <article-title>Immunosuppression and Chagas disease: a management
challenge</article-title>
          <source>PLOS Negl Trop Dis</source>
          <year>2013</year>
          <volume>7</volume>
          <elocation-id/>
        </element-citation>
      </ref>
      <ref id="B26">
        <label>26</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pittella</surname>
              <given-names>JE</given-names>
            </name>
          </person-group>
          <article-title>Central nervous system involvement in Chagas disease: a
hundred-year-old history</article-title>
          <source>Trans R Soc Trop Med Hyg</source>
          <year>2009</year>
          <volume>103</volume>
          <fpage>973</fpage>
          <lpage>978</lpage>
          <pub-id pub-id-type="pmid">19457529</pub-id>
        </element-citation>
      </ref>
      <ref id="B27">
        <label>27</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Qvarnstrom</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Schijman</surname>
              <given-names>AG</given-names>
            </name>
            <name>
              <surname>Veron</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Aznar</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Steurer</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>da Silva</surname>
              <given-names>AJ</given-names>
            </name>
          </person-group>
          <article-title>Sensitive and specific detection of Trypanosoma cruzi DNA in clinical
specimens using a multi-target real-time PCR approach</article-title>
          <source>PLOS Negl Trop Dis</source>
          <year>2013</year>
          <volume>6</volume>
          <elocation-id/>
        </element-citation>
      </ref>
      <ref id="B28">
        <label>28</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rassi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Amato</surname>
              <given-names>V</given-names>
              <suffix>Neto</suffix>
            </name>
            <name>
              <surname>de Siqueira</surname>
              <given-names>AF</given-names>
            </name>
            <name>
              <surname>Ferriolli</surname>
              <given-names>F</given-names>
              <suffix>Filho</suffix>
            </name>
            <name>
              <surname>Amato</surname>
              <given-names>VS</given-names>
            </name>
            <name>
              <surname>Rassi</surname>
              <given-names>A</given-names>
              <suffix>J&#xFA;nior</suffix>
            </name>
          </person-group>
          <article-title>Efeito protetor do benznidazol contra a reativa&#xE7;&#xE3;o parasit&#xE1;ria em
pacientes cronicamente infectados pelo Trypanosoma cruzi e tratados com cortic&#xF3;ide
em virtude de afec&#xE7;&#xF5;es associadas</article-title>
          <source>Rev Soc Bras Med Trop</source>
          <year>1999</year>
          <volume>32</volume>
          <fpage>475</fpage>
          <lpage>482</lpage>
          <pub-id pub-id-type="pmid">10881079</pub-id>
        </element-citation>
      </ref>
      <ref id="B29">
        <label>29</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sartori</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Ibrahim</surname>
              <given-names>KY</given-names>
            </name>
            <name>
              <surname>Nunes Westphalen</surname>
              <given-names>EV</given-names>
            </name>
            <name>
              <surname>Braz</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Oliveira</surname>
              <given-names>OC</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>Gakiya</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Manifestations of Chagas' disease (American trypanosomiasis) in
patients with HIV/AIDS</article-title>
          <source>Ann Trop Med Parasitol</source>
          <year>2007</year>
          <volume>101</volume>
          <fpage>31</fpage>
          <lpage>50</lpage>
          <pub-id pub-id-type="pmid">17244408</pub-id>
        </element-citation>
      </ref>
      <ref id="B30">
        <label>30</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sarquis</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Borges-Pereira</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Mac Cord</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Gomes</surname>
              <given-names>TF</given-names>
            </name>
            <name>
              <surname>Cabello</surname>
              <given-names>PH</given-names>
            </name>
            <name>
              <surname>Lima</surname>
              <given-names>MM</given-names>
            </name>
          </person-group>
          <article-title>Epidemiology of Chagas disease in Jaguaruana, Cear&#xE1;. Brazil. I.
Presence of triatomines and index of Trypanosoma cruzi infection in four
localities of a rural area</article-title>
          <source>Mem Inst Oswaldo Cruz</source>
          <year>2004</year>
          <volume>99</volume>
          <fpage>263</fpage>
          <lpage>270</lpage>
          <pub-id pub-id-type="pmid">15273797</pub-id>
        </element-citation>
      </ref>
      <ref id="B31">
        <label>31</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Souto</surname>
              <given-names>RP</given-names>
            </name>
            <name>
              <surname>Zingales</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Sensitive detection and strain classification of Trypanosoma cruzi by
amplification of a ribosomal RNA sequence</article-title>
          <source>Mol Biochem Parasitol</source>
          <year>1993</year>
          <volume>62</volume>
          <fpage>45</fpage>
          <lpage>52</lpage>
          <pub-id pub-id-type="pmid">8114825</pub-id>
        </element-citation>
      </ref>
      <ref id="B32">
        <label>32</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vaidian</surname>
              <given-names>AK</given-names>
            </name>
            <name>
              <surname>Weiss</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Tanowitz</surname>
              <given-names>HB</given-names>
            </name>
          </person-group>
          <article-title>Chagas' disease and AIDS</article-title>
          <source>Kinetoplastid Biol Dis</source>
          <year>2004</year>
          <volume>3</volume>
          <fpage>2</fpage>
          <lpage>2</lpage>
          <pub-id pub-id-type="pmid">15142278</pub-id>
        </element-citation>
      </ref>
      <ref id="B33">
        <label>33</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Westenberger</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Barnab&#xE9;</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Campbell</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Sturm</surname>
              <given-names>NR</given-names>
            </name>
          </person-group>
          <article-title>Two hybridization events define the population structure of
Trypanosoma cruzi</article-title>
          <source>Genetics</source>
          <year>2005</year>
          <volume>171</volume>
          <fpage>527</fpage>
          <lpage>543</lpage>
          <pub-id pub-id-type="pmid">15998728</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
